Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Biogen Inc. Transaction History
Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main
- $91.1 Billion
- Q4 2024
A detailed history of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main transactions in Biogen Inc. stock. As of the latest transaction made, Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main holds 72,818 shares of BIIB stock, worth $10.5 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
72,818
Previous 76,032
4.23%
Holding current value
$10.5 Million
Previous $14.7 Million
24.45%
% of portfolio
0.01%
Previous 0.02%
Shares
33 transactions
Others Institutions Holding BIIB
# of Institutions
1,001Shares Held
131MCall Options Held
1.77MPut Options Held
2.34M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.41 Billion0.05% of portfolio
-
Primecap Management CO Pasadena, CA16MShares$2.31 Billion1.94% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.09 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.4MShares$1.06 Billion0.05% of portfolio
-
Wellington Management Group LLP Boston, MA4.93MShares$709 Million0.14% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $20.7B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...